Ibex director Khaishgi Mohammedulla sells $31,815 in common shares

Published 23/01/2025, 09:12 am
IBEX
-

WASHINGTON—Khaishgi Mohammedulla, a director at IBEX Ltd (NASDAQ:IBEX), recently sold a portion of his holdings in the company. According to a filing with the Securities and Exchange Commission, Mohammedulla sold a total of 1,414 common shares on January 21, 2025. The sale comes as IBEX trades near its 52-week high of $22.52, having delivered an impressive 35% return over the past six months. According to InvestingPro analysis, the company maintains a strong financial health score and trades at an attractive P/E ratio of 11.2. The transactions were executed at prices ranging from $22.50 to $22.5001 per share, amounting to a total sale value of $31,815.

Following these transactions, Mohammedulla holds 96,712 shares indirectly as the trustee of the Allibhoy Khaishgi Family Foundation, and 221,744 shares directly. The sales were part of a pre-arranged trading plan.

In other recent news, IBEX Ltd has made significant strides in its operations. The company recently completed a $70 million share repurchase from The Resource Group International Limited (TRGI), effectively altering its ownership structure and ending its status as a "controlled company" under Nasdaq rules. The repurchase involved 3,562,341 of its common shares, with payment structured through a combination of cash and a convertible promissory note.

This development coincided with IBEX Ltd's strong start to the fiscal year 2025. The company reported a record Q1 revenue of $129.7 million, a 4.1% increase from the previous year. Adjustments to EBITDA and EPS also saw increases, leading the company to raise its full-year revenue guidance to between $515 million and $525 million.

In addition to these financial developments, IBEX Ltd also made changes to its board. The board now consists of a majority of independent directors, following a shareholder vote that set the maximum number of directors at eight. Shareholders also approved the appointment of Deloitte & Touche LLP as the company's auditor for the upcoming fiscal year.

As a result of these recent developments, IBEX Ltd now operates with a robust financial health score, indicating strong liquidity and efficient operations. This score, combined with the company's strategic moves, suggests a proactive approach to delivering value to shareholders.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.